CenterWatch Tracks Emerging Markets of Clinical Research with Release of New Book
Boston, MA.–April 19, 2007–CenterWatch, which covers clinical research worldwide through its market research, newsletters and books, has been tracking the progress of pharmaceutical companies, biotech companies and contract research organizations as they expand their clinical research enterprise into emerging markets in an effort to improve drug development timelines. The percentage of Form FDA 1572s filed by investigators abroad has nearly doubled between 2001 and 2006, indicating a dramatic increase in global clinical trial participation by non-U.S. investigators.
The Emerging Markets of Clinical Research is a comprehensive resource that provides original CenterWatch data on topics including: regulatory and business landscape, market intelligence, patient recruitment opportunities, investigator training and patient recruitment, CRO and pharmaceutical company strategies and experience, CRO opportunities, and size and growth of the emerging clinical research markets.
The new 200+-page book features hundreds of interviews with clinical research professionals, and market research articles and charts analyzing emerging markets in clinical research, including Russia, China, India, Central and Eastern Europe, South Africa and Africa, Asia/Pacific and Latin America.
"Many countries in Asia, Latin America and Eastern Europe as well as South Africa, have now either adopted ICH-GCP as a guideline, or formally made ICH-GCP law. This adoption has revolutionized the international research and development strategy of pharmaceutical and biotechnology companies and contract research organizations of all sizes. Rare is the phase III clinical trial initiated today that includes no plan for conduct in countries outside the U.S., Canada and Western Europe," said Sara Gambrill, author of The Emerging Markets of Clinical Research and Senior Editor at CenterWatch.
Who needs The Emerging Markets of Clinical Research:
- Biotech and pharmaceutical companies heads of research
- Business intelligence and market intelligence analysts for CROs, pharmaceutical and biotech companies and medical device companies
- Portfolio managers, investment analysts, and hedge funds
- CRO executives and business development directors
- Trial management companies
- Site management organizations
- Market research/competitive intelligence professionals,
- Government officials in emerging clinical research markets
To order a copy of The Emerging Markets of Clinical Research for $499 (+s/h), click here to download an order form or call us at 800-765-9647 and ask for code 3555.
To find out more information, contact us at (866) 219-3440, ext. 4 or email firstname.lastname@example.org.